In the current trading session, Galmed Pharmaceuticals Ltd’s (GLMD) stock is trading at the price of $1.38, a fall of -0.50% over last night’s close. So, the stock is trading at a price that is -94.19% less than its 52-week high of $23.80 and 20.27% better than its 52-week low of $1.15. Based on the past 30-day period, the stock price is -27.98% below the high and +5.15% above the low.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, GLMD’s SMA-200 is $2.0831.
GLMD’s price to book ratio for the most recent quarter was 0.19, resulting in an 0.48 price to cash per share for the period.
How does Galmed Pharmaceuticals Ltd (GLMD) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 1 brokerage firms that recommend the stock as a Hold. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 3.00 in simple terms.
Galmed Pharmaceuticals Ltd (NASDAQ: GLMD) Ownership Details
I will give a breakdown of the key shareholders in Galmed Pharmaceuticals Ltd (GLMD). Recent figures show that the company’s insiders hold 1.19% of shares. A total of 17 institutional investors hold shares in the company, making 1.42% of its stock and 1.43% of its float.
Jun 30, 2025, it was reported that the Company’s largest institutional holder is Delaware Group Equity Funds IV-Macquarie Healthcare Fund holding total of 1.7 shares that make 0.03% of the company’s total number of shares and are currently priced at 2270.0.
An overview of Galmed Pharmaceuticals Ltd’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Galmed Pharmaceuticals Ltd (GLMD) traded 215,521 shares per day, with a moving average of $1.4622 and price change of -0.2401. With the moving average of $1.7235 and a price change of -0.2801, about 326,320 shares changed hands on average over the past 50 days. Finally, GLMD’s 100-day average volume is 1,190,477 shares, alongside a moving average of $1.5711 and a price change of +0.0499.
